Charge variant analysis of monoclonal antibodies

Charge variants are recognised Critical Quality Attribute of therapeutic monoclonal antibodies as they can significantly impact product efficacy and stability. These variants arise from multiple post-translational modifications and degradation pathways, leading to a high level of heterogeneity that must be carefully controlled. Advanced analytical techniques are therefore required not only to separate and quantify these variants, but also to identify their structural origin.

This application note presents a comprehensive analytical strategy combining capillary isoelectric focusing (cIEF), ion-exchange chromatography (IEX), and MS-based approaches to address these challenges across different stages of development.

Download the full technical application note below

Analytical performance highlights

Combination of orthogonal techniques including cIEF, IEX, and (2D-)LC/MS for comprehensive charge variant analysis

• cIEF and icIEF enable separation of isoforms based on isoelectric point with generally good resolution and minimal method optimisation
• IEX provides high-resolution separation based on surface charge, with salt-gradient methods offering superior resolution and pH-gradient methods enabling more generic workflows
• Improved sensitivity of IEX allows accurate quantification of minor isoforms compared to cIEF
• Identification strategies include enzymatic digestion, fraction collection, 2D-LC/MS, and emerging IEX/MS approaches

Benefits for your mAb development programme

A robust charge variant analysis strategy is critical to ensure product quality, consistency, and regulatory compliance. By combining complementary analytical techniques, this approach enables both detailed characterisation and reliable routine monitoring.

• Enables comprehensive characterisation of charge heterogeneity across development stages
• Supports informed method selection (cIEF vs IEX, salt vs pH gradient) based on analytical goals such as identification or quantification
• Improves detection and accurate quantification of minor variants, critical for quality control
• Facilitates method robustness and reproducibility through the use of generic or platform approaches where applicable
• Enables regulatory-compliant characterisation through advanced MS-based identification techniques

By aligning analytical methods with project needs, this strategy ensures efficient and reliable charge variant assessment.

Typical applications

• Characterisation of charge variants in therapeutic monoclonal antibodies
• Quantification of acidic and basic isoforms for quality control and release testing
• Stability studies to monitor degradation-induced charge heterogeneity
• Identification of variants using enzymatic treatment and MS-based workflows
• Analysis of complex molecules such as antibody-drug conjugates